Logo image of BLIV

BELIVE HOLDINGS (BLIV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BLIV - KYG096751022 - Common Stock

3.67 USD
-0.28 (-7.09%)
Last: 12/24/2025, 8:15:31 PM
3.51 USD
-0.16 (-4.36%)
After Hours: 12/24/2025, 8:15:31 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BLIV. BLIV was compared to 278 industry peers in the Software industry. BLIV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BLIV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year BLIV has reported negative net income.
BLIV Yearly Net Income VS EBIT VS OCF VS FCFBLIV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -2M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -100.25%, BLIV is doing worse than 92.09% of the companies in the same industry.
BLIV's Return On Equity of -104.76% is on the low side compared to the rest of the industry. BLIV is outperformed by 78.42% of its industry peers.
Industry RankSector Rank
ROA -100.25%
ROE -104.76%
ROIC N/A
ROA(3y)-247.96%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLIV Yearly ROA, ROE, ROICBLIV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 2K -2K 4K

1.3 Margins

BLIV has a worse Gross Margin (45.58%) than 71.94% of its industry peers.
BLIV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLIV Yearly Profit, Operating, Gross MarginsBLIV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -100 -200

6

2. Health

2.1 Basic Checks

BLIV does not have a ROIC to compare to the WACC, probably because it is not profitable.
BLIV has less shares outstanding than it did 1 year ago.
The debt/assets ratio for BLIV is higher compared to a year ago.
BLIV Yearly Shares OutstandingBLIV Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
BLIV Yearly Total Debt VS Total AssetsBLIV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M

2.2 Solvency

An Altman-Z score of 65.86 indicates that BLIV is not in any danger for bankruptcy at the moment.
BLIV has a better Altman-Z score (65.86) than 98.56% of its industry peers.
BLIV has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.00, BLIV is doing good in the industry, outperforming 67.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 65.86
ROIC/WACCN/A
WACC11.01%
BLIV Yearly LT Debt VS Equity VS FCFBLIV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M

2.3 Liquidity

A Current Ratio of 24.19 indicates that BLIV has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 24.19, BLIV belongs to the top of the industry, outperforming 97.84% of the companies in the same industry.
BLIV has a Quick Ratio of 24.19. This indicates that BLIV is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BLIV (24.19) is better than 97.84% of its industry peers.
Industry RankSector Rank
Current Ratio 24.19
Quick Ratio 24.19
BLIV Yearly Current Assets VS Current LiabilitesBLIV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

0

3. Growth

3.1 Past

BLIV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.92%.
BLIV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -40.15%.
EPS 1Y (TTM)-64.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-40.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLIV Yearly Revenue VS EstimatesBLIV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M 4M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLIV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLIV Price Earnings VS Forward Price EarningsBLIV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLIV Per share dataBLIV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BLIV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BELIVE HOLDINGS

NASDAQ:BLIV (12/24/2025, 8:15:31 PM)

After market: 3.51 -0.16 (-4.36%)

3.67

-0.28 (-7.09%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.65%
Inst Owner ChangeN/A
Ins Owners8.1%
Ins Owner ChangeN/A
Market Cap39.86M
Revenue(TTM)2.20M
Net Income(TTM)-10.73M
AnalystsN/A
Price TargetN/A
Short Float %0.12%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.27
P/FCF N/A
P/OCF N/A
P/B 5
P/tB 5.26
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.16
BVpS0.73
TBVpS0.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -100.25%
ROE -104.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.58%
FCFM N/A
ROA(3y)-247.96%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 24.19
Quick Ratio 24.19
Altman-Z 65.86
F-ScoreN/A
WACC11.01%
ROIC/WACCN/A
Cap/Depr(3y)146.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-164.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-463.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1881.47%
OCF growth 3YN/A
OCF growth 5YN/A

BELIVE HOLDINGS / BLIV FAQ

Can you provide the ChartMill fundamental rating for BELIVE HOLDINGS?

ChartMill assigns a fundamental rating of 2 / 10 to BLIV.


Can you provide the valuation status for BELIVE HOLDINGS?

ChartMill assigns a valuation rating of 0 / 10 to BELIVE HOLDINGS (BLIV). This can be considered as Overvalued.


How profitable is BELIVE HOLDINGS (BLIV) stock?

BELIVE HOLDINGS (BLIV) has a profitability rating of 0 / 10.


Can you provide the financial health for BLIV stock?

The financial health rating of BELIVE HOLDINGS (BLIV) is 6 / 10.